FAMVIR

This brand name is authorized in Australia, Austria, Canada, Cyprus, Estonia, Finland, Hong Kong SAR China, Ireland, Italy, Japan, Malta, New Zealand, South Africa, Spain, UK.

Active ingredients

The drug FAMVIR contains one active pharmaceutical ingredient (API):

1	Famciclovir UNII QIC03ANI02 - FAMCICLOVIR
	Famciclovir is the oral prodrug of penciclovir. Famciclovir is rapidly converted in vivo into penciclovir, which has in vitro activity against herpes simplex viruses (HSV types 1 and 2), varicella zoster virus (VZV), Epstein-Barr virus and cytomegalovirus.
	Read more about Famciclovir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FAMVIR Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AB09	Famciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2274Q, 8002E, 8092X, 8217L, 8896F, 8897G
CA	Health Products and Food Branch	02177102, 02229110, 02229129
EE	Ravimiamet	1073270, 1816725
ES	Centro de información online de medicamentos de la AEMPS	60609, 61597, 65027
FI	Lääkealan turvallisuus- ja kehittämiskeskus	166562, 463443
GB	Medicines & Healthcare Products Regulatory Agency	142317, 142319, 21917, 21931, 21933, 21958, 21959
HK	Department of Health Drug Office	39023, 39905, 45046
IE	Health Products Regulatory Authority	24477, 66208, 66214, 66276, 66285
IT	Agenzia del Farmaco	029172018, 029172057
JP	医薬品医療機器総合機構	6250031F1021
MT	Medicines Authority	MA1333/00101, MA1333/00102, MA1333/00103
NZ	Medicines and Medical Devices Safety Authority	7599
ZA	Health Products Regulatory Authority	29/20.2.8/0189, 30/20.2.8/0277